Dirk Arnold Selected Research

Dirk Arnold Research Topics

Disease

57	Colorectal Neoplasms (Colorectal Cancer) 02/2023 - 10/2005
40	Neoplasms (Cancer) 02/2023 - 07/2002
25	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2008
19	Rectal Neoplasms (Rectal Cancer) 01/2021 - 10/2006
10	Disease Progression 01/2023 - 01/2012
10	Adenocarcinoma 01/2023 - 01/2012
9	Colonic Neoplasms (Colon Cancer) 01/2022 - 09/2008
7	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 06/2006
5	COVID-19 01/2023 - 01/2021
4	Stomach Neoplasms (Stomach Cancer) 10/2023 - 05/2010
4	Hypertension (High Blood Pressure) 01/2023 - 07/2009
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 08/2022 - 06/2006
4	Diarrhea 01/2022 - 01/2007
4	Thrombosis (Thrombus) 09/2021 - 07/2002
4	Liver Diseases (Liver Disease) 01/2018 - 01/2012
3	Cholangiocarcinoma 02/2024 - 07/2002
3	Liver Neoplasms (Liver Cancer) 02/2023 - 07/2002
3	Microsatellite Instability 01/2023 - 01/2018
3	Carcinoma (Carcinomatosis) 01/2023 - 08/2011
2	Hepatocellular Carcinoma (Hepatoma) 02/2023 - 01/2021
2	Asthenia 01/2023 - 01/2013
2	Vomiting 10/2022 - 07/2012
2	Paralysis (Palsy) 01/2022 - 01/2017
2	Anus Neoplasms (Anal Cancer) 12/2021 - 01/2020
2	Ascites 01/2021 - 06/2014
2	Fatigue 01/2019 - 01/2015
2	Peritoneal Neoplasms 02/2013 - 11/2011
2	Hemorrhage 01/2013 - 01/2010
2	Pathologic Complete Response 10/2010 - 01/2007
1	Anxiety Disorders (Anxiety Disorder) 01/2023
1	Facial Paralysis (Facial Palsy) 01/2023
1	Heart Arrest (Cardiac Arrest) 01/2023
1	Intestinal Perforation 01/2023
1	Stomatitis 01/2023
1	Hand-Foot Syndrome 01/2023

Drug/Important Bio-Agent (IBA)

31	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 10/2005
27	Bevacizumab (Avastin)FDA Link 02/2023 - 01/2008
22	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 07/2002
14	Capecitabine (Xeloda)FDA Link 01/2023 - 10/2006
12	Leucovorin (Folinic Acid)FDA Link 01/2023 - 07/2002
12	Cetuximab (Erbitux)FDA Link 01/2023 - 03/2008
11	Irinotecan (Camptosar)FDA LinkGeneric 10/2022 - 06/2006
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2010
4	Yttrium-90IBA 02/2024 - 04/2020
4	regorafenibIBA 01/2023 - 12/2014
4	PlatinumIBA 01/2022 - 01/2012
4	ErbB Receptors (EGF Receptor)IBA 10/2018 - 10/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 09/2008
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 06/2006
3	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2017
3	Docetaxel (Taxotere)FDA Link 09/2017 - 02/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 08/2011
3	afliberceptIBA 01/2016 - 12/2014
3	catumaxomabIBA 10/2015 - 08/2011
2	Biosimilar PharmaceuticalsIBA 02/2023 - 01/2021
2	atezolizumabIBA 01/2023 - 08/2022
2	Trastuzumab (Herceptin)FDA Link 01/2023 - 08/2012
2	trifluridine tipiracil drug combinationIBA 01/2023 - 01/2019
2	Epidermal Growth Factor (EGF)IBA 01/2023 - 08/2011
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 05/2011
2	olaparibIBA 12/2022 - 01/2019
2	AlbuminsIBA 12/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 11/2022 - 08/2020
2	C-Reactive ProteinIBA 01/2022 - 09/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 07/2015
2	Carcinoembryonic AntigenIBA 10/2019 - 01/2017
2	ParaffinIBA 01/2018 - 08/2011
2	Formaldehyde (Formol)FDA Link 01/2018 - 08/2011
2	Gemcitabine FDA Link 07/2015 - 11/2011
2	Monoclonal AntibodiesIBA 02/2013 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 05/2011 - 10/2005
2	XELOXIBA 09/2008 - 01/2007
2	Gefitinib (Iressa)FDA Link 12/2006 - 10/2005
1	HMPL-013IBA 01/2023
1	erdafitinibIBA 01/2023
1	pertuzumabIBA 01/2023
1	cobimetinibIBA 01/2023
1	VemurafenibIBA 01/2023
1	BilirubinIBA 12/2022
1	Oxygen (Dioxygen)IBA 11/2022
1	AntiemeticsIBA 10/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022

Therapy/Procedure

43	Therapeutics 10/2023 - 12/2005
40	Drug Therapy (Chemotherapy) 01/2023 - 07/2002
12	Chemoradiotherapy 01/2021 - 01/2010
11	Radiotherapy 02/2023 - 01/2007
10	Adjuvant Chemotherapy 09/2020 - 01/2008
9	Combination Drug Therapy (Combination Chemotherapy) 01/2016 - 10/2005
8	Neoadjuvant Therapy 09/2017 - 01/2008
5	Microspheres (Microsphere) 02/2024 - 01/2020
4	Hyperthermic Intraperitoneal Chemotherapy 12/2018 - 11/2011
3	Immunotherapy 08/2022 - 08/2020
3	Induction Chemotherapy 01/2016 - 12/2010
3	Catheters 01/2012 - 09/2008
2	Electrodes (Electrode) 01/2023 - 01/2017
2	Duration of Therapy 09/2020 - 01/2018
2	Cytoreduction Surgical Procedures 12/2018 - 11/2011
2	Palliative Care (Palliative Therapy) 10/2017 - 01/2009
2	Combined Modality Therapy 10/2015 - 11/2011
1	Artificial Respiration (Mechanical Ventilation) 01/2023